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Abstract Skin-derived antileukoproteinase (SKALP), Key words SKALP • Wound healing • 
also known as elafin, is a proteinase inhibitor with Antileukoproteinase • Elastase 
specificity for polymorphonuclear leucocyte (PMN)- 
derived elastase and proteinase-3. SKALP is absent in   
normal human epidermis, but is strongly induced in Introduction 
inflammatory dermatoses such as psoriasis. SKALP is
putatively involved in the regulation of cutaneous in- Proteinase activity is regulated systemically by numerous
flammation by inhibiting PMN derived proteinases. plasma-derived inhibitors, such as a!-proteinase inhibitor
The aim of this study was to investigate SKALP ex- and a 2-macroglobulin. However, in normal human epi-
pression and PMN infiltration during wound healing dermis only low levels of antiproteinase activity directed
in human skin. This was examined in healing exci- against the major polymorphonuclear leucocyte (PMN)-
sional wounds in normal skin and in impaired healing derived proteinases (e.g. elastase, proteinase-3 and cathep-
in various types of chronic venous ulcers. Tissues were sin G) can be detected. Antiproteinase activity is upregu-
analysed using immunohistocliemistry and Northern lated in inflammatory skin diseases such as psoriasis [5,
blot analysis. Healing of excisional wounds was stud- 18-20] and epidermal tumours [2]. In previous studies we
ied from day 0 to day 14. An influx of PMN was seen and others have characterized this antiproteinase activity
rapidly after wounding and was maximal between day and found it to be an inducible inhibitor of elastase and
2 and 4 and then subsided. SKALP was induced within proteinase 3 [23]. This inhibitor has been named skin-de-
48 h and was expressed in the suprabasal keratino- rived antileukoproteinase (SKALP) [18], also known as
cytes of the wound edge and the migrating epidermal elafin [23, 24] or elastase-specific inhibitor (ESI) [15 |.
sheet. SKALP expression was maximal on day 4 and Cloning of the SKALP cDNA and gene has revealed that
was downregulated at the time of complete reepithe- the molecule contains several N-terminal transglutami-
lialization (7-14 days). In venous ulcers, PMN were nase substrate motifs, in addition to the antiproteinase do-
abundant in the wound bed and scarce under the main that was already known [11, 12, 14]. SKALP is a se-
wound edge. SKALP was strongly expressed in the creted molecule, and we have recently demonstrated its
keratinocytes of the wound edge in all types of ulcers presence in urine and plasma of psoriatic patients [1,4].
studied. In the wound bed, SKALP was not detectable.
Our results suggest that S
SKALP may be involved in the regulation of euta-
P plays a role in the neous animation by inhibiting PMN-derived o
acute, inflammatory phase of wound healing. From teinases. However, no direct evidence for its function in 
the kinetics and topology of SKALP expression we vivo is available at present. Previous investigations have
surmise that it negatively regulates PMN infiltration.
Some of the results reported here were presented at the meeting 
of the European Society for Dennatological Research in Vienna,
September 1994.
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SKALP expression in skin • l a s t s ,
skin tumours) but have not provided information on the 
dynamics of SKALP induction or the temporospatial rela­
tionship with PMN infiltration at the histological level. 
Here we studied the kinetics of inflammation and SKALP 
induction .in wound healing of normal skin, which al­
lowed us to examine these processes in more detail. In ad­
dition, we studied the spatial relationship between SKALP 
expression and infiltrating PMN in chronic venous ulcers. 
Our results demonstrate a coordinated expression of epi­
dermal SKALP and PMN influx in normal wound heal-
459
ing. C hrome venous ulcers appear not to
annnalory phase of wound healing, and show
flammatory cells was present shortly after injury (24 h),
and the wound bed was filled with fibrinous material (not 
continuous presence ol PMN and sustained expression of shown). After 4 days all wounds were covered with a
SKALP by the keratinoeytes ol the wound margin. scab. Immunohistochemical staining for leucocyte elas-
tase confirmed the presence of large amounts of PMN in 
the wound bed from day 1 to day 4. The marginal zone of 
this cellular infiltrate was located just beneath the wound 
edge. As early as within 2 days reepithelialization had 
started, and a sheet of ingrowing keratinoeytes was visi- 
A polyclonal antiserum against recombinant SKALP was obtained ble- UP to 4 days after injury, elastase-positive PMN were
Materials and methods
Chemicals and antisera
as described previously 120]. Recombinant SKALP was a kind gift 
from Dr. N. Russell. I Cl Pharmaceuticals, UK.
A monoclonal mouse antibody to human neutrophil elastase, 
swineantirubbit immunoglobulin conjugated with horseradish per- 
oxidase tSWARPO) and rabbit-antimouse immunoglobulin conju­
gated with horseradish peroxidase (RAMPO) were all obtained 2 w eek s the
prominently present. After 1 week reepithelialization was 
complete in all wounds. At this time the number of elas-
cells had decreased considerably. Only a few
in the original wound bed. After 
s had resumed their normal strat-
sci
from Dakopatts, tilostrup, Denmark.
samples
To study impaired wound healing, biopsies were taken under local 
anaesthesia from the margins of eight chronic venous or mixed ve-
ification. However, the epidermis still remained acan- 
thotic, and rete ridges were lacking. The cellular infíltrate 
consisted of mononuclear cells, fibroblasts and endothe­
lial cells. No PMN were present at this time.
nous/arteriolar ulcers, after the patients had given their informed C hron ic  u lc e r s  
consent and permission from the local medical-ethical committee 
had been obtained. Patients ranged in age from 29 to 70 years. A
rectangle of tissue approximately 10 x 3 mm was excised to in- On histological examination three zones could be identi-
elutle the surrounding intact skin, the ulcer edge and the ulcer bed. fled within each biopsy: the ulcer bed, the ulcer margin
I he biopsies weie taken in clinically ditierent stages ol wound an(j ^ie  surrounding intact skin. The surrounding skin ap-
healmg: two biopsies were taken from an ulcer in the necrotic ,  ^ , , . . . . r ° ,
phase, three in the necrotic/granulating phase and three in the reep- Petir normal in most biopsies, except for the acan-
itheliali/ation phase. All patients received local wound care and thotic epidermis. The ulcer margin was covered by epi-
ambulant compression therapy prior to the biopsy. This treatment dermis that m igrated  over, within or under the fibrinous
remained unchanged after the biopsy. All biopsy sites healed 
within 1 2 weeks, without complications.
exudate. The ulcer bed varied from a fibrinous exudate to
... , ’ , , ...., • , i i* ■ > ii r ii  ^ 4, granulating tissue. In all cases many infiltrating cells werelo  study wound healing in normal skin the following wound . , r ,, , j  • •
model was used in eight subjects with normal skin: after obtaining 
informed consent four wounds were made under local anaesthesia 
on the outside of the upper arm on day 0 using a 3-mm punch. The 
wound depth was approximately 1 mm. On days 2, 4, 7 and 14 
standard 4 mm punch biopsies were taken over the previously 
made wounds.
visible. In all the ulcer stages studied, similar densities o f 
elastase-positive cells (PMN) were found within the ulcer
Expression of SKALP during wound healing
luieh biopsy was rinsed in phosphate-buffered saline (PBS) before 
f i vinü in buffered formalin. After 24 h, tissues were embedded in Within
paraffin wax, sectioned at 5 pm and mounted on 3-aminoalkyltri- upper layers of the epidermis adjacent to the wound (Figs. 
ethoxvsilane coated slides. Sections were deparalTini/.ed, rehy- 1, 2). On days 2 and 4 expression of SKALP was seen in 
dialed and preincubated with either normal swine set um oi nomuil ajj ccjj jay ers 0 f  the migrating sheet of epidermal cells ex-
rahbtt serum. I he sections were then incubated either with poly- , , ■ . ,« • .  ,, C\ rp • , . ,
clonal anti SKA1JVelalin serum or monoclonal anti-elasiase. After  eept lot the basal layet (Pigs. 3, 4,  5).  This suptabasa cy­
toplasmic staining of the neoepidermis decreased towards
the intact normal skin. Most of the wounds were already
incubation with peroxidase conjugated second antibodies, the sec
were developed with aminoethylearba/.ole as the ehro
mogenie .substrate.
PMN infiltration during wound healing
I ;r wounding. Staining for SKALP at s
stage was positive up to the original wound e
7). SKALP expression was almost completely 
lated 2 weeks after wounding. In some sections positive 
staining was still visible in the upper layers of the stratum
Normal wound healing
Routine 11 à  ti staining of biopsies taken over a 14-day
Chronic ulcers
period s the well features of normal wound The expression patterns of SKALP were identical for all
healing in cxeisional wounds. A dense infiltrate oí in- *ee ulcer stages. A positive suprabasal staining was
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Ibund in the epidermis at the ulcer margins and in the mi- ithelialization. Antiproteinase activity, therefore, could be 
grating sheet (Fig. 8). SKALP expression gradually di- of crucial importance in an envir
minished towards normal skin.
Discussion
which is beneficial for epidermal migration by reducing 
proteolysis of matrix components.
In previous work we have shown that human epider­
mal kerytinocytes are capable of producing the elasta.se/ 
proteinase-3 inhibitor SKALP, in the context of the hyper- 
Wound repair is a complex process comprising inflamma- proliferative/regenerative differentiation programme. This 
tion, reepithelialization, matrix synthesis and tissue re- was shown both in vivo in psoriatic lesions and 
modelling. These processes are essential to restore the stripping [3, 20J. We report here the kinetics of SKALP 
structural and functional integrity of the damaged tissue, induction in full-thickness wounds, and its presence in 
In the early inflammatory phase of wound healing, PMN chronic ulcers. In excisional wounds a PMN influx was
and was maximal between
was
in the suprabasal
expression was
invade the wound area [7 J. The main function of the PMN seen rapidly after won
at the wound site is the elimination of contaminating bac- day 2 and day 4, then s
leria via phagocytosis and subsequent enzymatic and ox- within 48 h and was ex
idative mechanisms [21, 22 ]. In normal human skin, inva- atinocytes of the
sion of PMN is observed as early as a few hours after maximal on day 4 and was downregulated at the time of
wounding, decreasing rapidly after several days [13]. In complete reepithelialization (7—14 days). This sequence
disturbed wound healing, e.g. chronic venous ulcers, of events suggests the SKALP gene expression and the in-
PMN remain present in the wound area [7]. It has recently flux of PMN are causally linked.
Sallenave et al. 116) have recently shown that leueobeen reported that leucocyte elastase is responsible for ex-
tensive fibronectin degradation in burn wounds [9], Fur- cyte elastase is itself capable of inducing SKALP gene ex- 
thermore, in wound fluid from chronic leg ulcers fibro- pression in pneumocyte cell lines. However, we were itn- 
nectin is almost completely degraded [10]. Since fibro- able to induce SKALP expression in 
nectin plays an important role in adhesion and migration of atinocytes under these conditions (Molhuizen et al., un- 
epidermal cells [8 ], degradation of fibronectin and other published observation). In vitro we have found that serum 
adhesive matrix components could impair proper reep- components can induce SKALP expression at the tran­
scriptional level [3]. Since acute inflammatory processes 
are usually accompanied by vasodilatation and oedema
*4 Fig. 1 Histology of a 1-day-old wound in the upper ami of a formation, this could very well be the relevant signal dur- 
healthy volunteer with immunoperoxidase staining for SKALP. ing in vivo wound healing. The observation of the imme- 
Note the lirst discrete signs ol SKALP expression (arrow) in the diate production of SKALP in the newly formed epider-
l  i  *« I i\ n / r t  •%ri /■% 4- f  U  fk  ■* /* i i-\ a n  /  \ *\ f  f  f  l*\ *‘v n  t « i  *-1 / «  i i 1 /  V V  jf 1 <  1 A ^  Iupper layers of the epidermis (e) adjacent to the wound (w) (x 45)
mis suggests an important role for SKALP in the early
Fig.2 Histology of a 1-day-old wound in the upper arm of a phase of the wound-healing process. SKALP could pro
healthy volunteer with an immunoperoxidase staining for SKALP. 
Detail of Fig. I. The first signs of SKALP expression (arrows) in
tect the neoepidermis against damage caused by elastase,
the upper layers of the epidermis (c) adjacent to the wound (vvj. (x thus leading to continuation ol ieepithelialization. Seue-
tion of SKALP counteracts degradation of adhesive ma-
Fig. 3 Histology of a 2-day-old wound in the upper arm of a
trix proteins by elastase and
healthy volunteer. Note the marked immunohistoehemical staining protection ol matiix components, 
for SKALP (arrows) in all suprabasal cell layers of the epidermis teiiere with PMN migration to the
(c) migrating under the scab (s). (x 180)
Fig. 4 Histology of a 4-day-old wound in the upper arm of a
In addition to 
could also in-
The observation that PMN accumulated in the wound bed
were abs near mamn .'re ; is
healthy volunteer. There is a strong suprabasal immunoperoxidase secreted, supports this suggestion.
staining for SKALP (arrows) in the epidermis (e) migrating under 
the scab f.v). (x 45)
As shown immunohistologically, SKALP was ex 
pressed at high levels in the wound margins of chronic ul Oft
Fig.5 Histology of a 4-day-old wound in the upper arm of a cers. Nevertheless, PMN were continuously present and
healthy volunteer. Detail of Fig. 4. There is a strong suprabasal im reepithelialization was severely impaired. Chronic ulcers
T - T T Ä * ’ f i " 1" » SKAhP, ^  appeared unable to progress through the normal stages of
of the epithelium (e) migrating under the scab f.v). (x 180)
Fig.6 Histology of a 7-day-old wound in the upper arm of a 
healthy volunteer. The wound is already closed underneath the 
scab (s). There is still a suprabasal staining present for SKALP (ar­
rows), mainly in the upper layers of the epidermis (e). (x 45)
îr arm of a
wound healing. A chronic ulcer represents as unstable
ammatory s
x of PMN) and a frustrated restorative re; 
ialization, SKALP expression). The
Fig. 7 Histology of a 7-day-old wound in the 
healthy volunteer. Detail of Fig. 6. Note the suprabasal im-
for ulcer formation are largely un
known. Active inflammation 44
munoperoxidase staining for SKALP (arrows) in the upper layers PMN-derived proteinases C
excessive secretion of 
saturate the local
of the epidermis (e) under the scab f.v). (x 180) tive mechanisms, as suggested by the massive breakdown
Fig.8 Histology of a chronic leg ulcer. The sheet of ingrowing ^  matrix pioteins in lllcci wound lluid ¡9|. Ihese li 
epidermis is indicated by a dotted line. Note the suprabasal, epi- may provide a rational basis tor the use of
dermal, cytoplasmic expression of SKALP (arrows). (X 45) hibitors as a therapeutic modality in chronic
462
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